Sarah Kim-Hellmuth

Sarah Kim-Hellmuth is a computational biologist and immunogenomics researcher affiliated with Helmholtz Munich and Ludwig Maximilian University of Munich (LMU). She holds positions as Group Leader Immunogenomics at Helmholtz Munich and Principal Investigator at the Dr. von Hauner Children’s Hospital, LMU Munich. Her research focuses on genetic regulation of immune responses in human tissues.

• MD from LMU and TU Munich
• Postdoctoral training at New York Genome Center and Columbia University
• Specialist training in Clinical Genetics at University of Bonn

Sarah’s work bridges computational genomics and immunology, emphasizing:

• Tissue- and cell type-specific QTLs
• Sex-specific gene expression patterns
• Genetic effects on immune response to pathogens
• Translational insights into autoimmune disease mechanisms

Her recent publications highlight genetic regulatory effects across human tissues and immune activation dynamics. Key trends include multi-omics integration and disease-relevant molecular mechanisms.

• Honors: ERC Starting Grant (2022), Ingrid zu Solms Award (2023), Emmy Noether Programme (2022)
• Grants: Helmholtz Young Investigator Group (2021), Marie Skłodowska-Curie Fellowship (2017)

She leads the Ped-COVID-19 study since 2020 and directs a research group at Helmholtz Munich, focusing on immune-related disease genetics.